A Phase I Single Blind Randomized Placebo Controlled Study to evaluate the Safety and Immunogenicity of Live Attenuated Tetravalent Recombinant Dengue Vaccine of HBI in Healthy Adults of 18 to 50 years of age
A Phase II/III Multicentric Randomized Single Blind Study to Compare the Immunogenicity and Safety of Diphtheria and Tetanus vaccine (Adsorbed) for Adults and Adolescents (Td vaccine) of HBI with BE Td�® Vaccine in two age groups of Healthy Subjects.
A Phase I Randomized Single Blind Placebo Controlled Study to Evaluate the Safety and Immunogenicity of Chikungunya Vaccine (Inactivated) of HBI when administered by two different dosage schedules to Healthy Subjects of 19 to 49 Years of age.
100 Clinical Results associated with Human Givens Institute
0 Patents (Medical) associated with Human Givens Institute
100 Deals associated with Human Givens Institute
100 Translational Medicine associated with Human Givens Institute